GISAID

GISAID is open-access to genetic data of influenza viruses,[3] and the coronavirus responsible for the COVID-19 pandemic.[4][5]

GISAID Initiative
AbbreviationGISAID
FormationMay 2008; 18 years ago (May 2008)
TypeNonprofit organization
Public–private partnership
PurposeGlobal health, research, education
HeadquartersMunich, Germany
Area served
Worldwide
MethodDonations and grants
Key people
  • Peter Bogner, (president)[1]
  • Ron A. M. Fouchier and John W. McCauley (co-chairs Scientific Advisory Council)[2]
Websitegisaid.org

GISAID is open-access to genetic data of influenza viruses,[3] and the coronavirus responsible for the COVID-19 pandemic.[4][5]

On January 10, 2020, the first whole-genome sequences of SARS-CoV-2 were made available on GISAID. This enabled global responses to the pandemic.[6] There was the first vaccines,[7] and diagnostic tests,[8] to detect SARS-CoV-2. GISAID helps watch for the emergence of new COVID-19 viral strains across the planet.[6][9]

Its establishment was an alternative to sharing avian influenza data by conventional public-domain archives.[10][3][11] GISAID has given rapid exchange of outbreak data[11] during the H1N1 pandemic[12][13] in 2009, the H7N9 epidemic[14][15] in 2013, and the COVID-19 pandemic[16][17] in 2020.

GISAID was recognized for its importance to world health by G20 health ministers in 2017,[18] and in 2020 the World Health Organization chief scientist called the data-science initiative "a game changer".[4]

References

  1. ↑ huaxia (November 1, 2019). "Chinese experts call for global cooperation in flu prevention". Xinhua News Agency. Archived from the original on July 9, 2020. Retrieved July 7, 2020.
  2. ↑ "Governance & Expertise: Scientific Advisory Council". GISAID. 2020. Retrieved July 7, 2020. The Scientific Advisory Council (SAC) comprises leading influenza scientists with expertise in epidemiology, human and veterinary virology and bioinformatics.
  3. ↑ 3.0 3.1 Shu, Yuelong; McCauley, John (2017). "GISAID: Global initiative on sharing all influenza data – from vision to reality". Eurosurveillance. 22 (13). doi:10.2807/1560-7917.ES.2017.22.13.30494. PMC 5388101. PMID 28382917.
  4. ↑ 4.0 4.1 Swaminathan, Soumya (December 17, 2020). "The WHO's chief scientist on a year of loss and learning". Nature. Retrieved December 20, 2020.
  5. ↑ Korber, Bette (August 20, 2020). "Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus". Cell. 182 (4): 812–827.e19. doi:10.1016/j.cell.2020.06.043. PMC 7332439. PMID 32697968. the global sampling of SARS-CoV-2 is being very capably addressed by the Global Initiative for Sharing All Influenza Data (GISAID) database
  6. ↑ 6.0 6.1 "CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains". BioSpectrum - Asia Edition. November 23, 2020. Retrieved December 24, 2020. GISAID is an essential component of COVID-19 R&D that enables real-time progress in the understanding of the geographical spread, circulation, and evolution of the SARS-CoV-2 virus
  7. ↑ Polack, Fernando (December 10, 2020). "Safety and Efficacy of the mRNA Covid-19 Vaccine". New England Journal of Medicine. 383 (27): 2603–2615. doi:10.1056/NEJMoa2034577. PMC 7745181. PMID 33301246. The development of BNT162b2 was initiated on January 10, 2020, when the SARS-CoV-2 genetic sequence was released by the Chinese Center for Disease Control and Prevention and disseminated globally by the GISAID (Global Initiative on Sharing All Influenza Data) initiative.
  8. ↑ Bohn, Mary Kathryn (October 7, 2020). "IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection". Clinical Chemistry and Laboratory Medicine. 58 (12): 1993–2000. doi:10.1515/cclm-2020-1412. PMID 33027042.
  9. ↑ Jameel, Shahid (2 April 2020). "Coronavirus pandemic highlights key need for science and partnerships". The Telegraph (Kolkata). Retrieved 29 December 2020.
  10. ↑ McDowell, Robin (May 15, 2008). "Indonesia hands over bird flu data to new database". Fox News. Associated Press. Retrieved June 7, 2020.
  11. ↑ 11.0 11.1 Elbe, Stefan; Buckland-Merrett, Gemma (January 10, 2017). "Data, disease and diplomacy: GISAID's innovative contribution to global health". Global Challenges. 1 (1): 33–46. Bibcode:2017GloCh...1...33E. doi:10.1002/gch2.1018. PMC 6607375. PMID 31565258.
  12. ↑ Schnirring, Lisa (June 25, 2009). "Pandemic reveals strengths of new flu database". Center for Infectious Disease Research and Policy. Retrieved June 7, 2020.
  13. ↑ "Viral gene sequences to assist update diagnostics for swine influenza A(H1N1)" (PDF). World Health Organization. April 25, 2009. Retrieved June 7, 2020.
  14. ↑ "The fight against bird flu". Nature. 496 (7446): 397. April 24, 2013. doi:10.1038/496397a. PMID 23627002.
  15. ↑ Larson, Christina (April 10, 2013). "CDC Races to Create a Vaccine for China's Latest Bird Flu Strain". Bloomberg BusinessWeek. Retrieved June 7, 2020.
  16. ↑ Prasad, R. (January 19, 2020). "What is the source of the new SARS-like disease reported in China?". The Hindu. Retrieved June 7, 2020.
  17. ↑ Ng, Kang-chung (January 12, 2020). "Wuhan pneumonia: Hong Kong set to develop new test for mystery virus after obtaining genetic sequence from mainland China". South China Morning Post. Retrieved June 7, 2020.
  18. ↑ Health Ministers (20 May 2017). "Berlin Declaration of the G20 Health Ministers" (PDF). German Ministry of Health. Retrieved 18 July 2017.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.